Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. In 1994, Novo Nordisk established its commercial operations in China, and built a local presence across the full value chain covering R&D, production, and commercial operations within the first three years. Deeply rooted in China for longer than three decades, Novo Nordisk has been continuously expanding investment and deepening the full value chain presence to better serve Chinese patients.